{
    "organizations": [],
    "uuid": "a42de17545113980e18c92ffdd8f72607f344e7a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-vbl-therapeutics-announces-q1-loss/brief-vbl-therapeutics-announces-q1-loss-per-share-0-24-idUSASC0A2QM",
    "ord_in_thread": 0,
    "title": "BRIEF-Vbl Therapeutics Announces Q1 Loss Per Share $0.24",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 17 (Reuters) - Vascular Biogenics Ltd:\n* VBL THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 LOSS PER SHARE $0.24 * SAYS CASH, CASH EQUIVALENTS AND SHORT-TERM BANK DEPOSITS AT MARCH 31, 2018, WERE $49.9 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-17T19:13:00.000+03:00",
    "crawled": "2018-05-18T19:39:13.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "vascular",
        "biogenics",
        "ltd",
        "vbl",
        "therapeutic",
        "announces",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "say",
        "cash",
        "cash",
        "equivalent",
        "bank",
        "deposit",
        "march",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}